Disturbed sleep is a prominent feature of fibromyalgia symptomatology and has been proposed as one of the core symptoms that should be systematically assessed in clinical trials for the treatment ...
The most common causes of ACD are the plants of the Rhus genus, poison ivy (toxicodendron radican), poison oak (toxicodendron quercifolium and toxicodendron diversilobum), and poison sumac ...
Diffuse (interstitial) lung disease includes a wide variety of relatively uncommon conditions presenting with characteristic clusters of clinical features and marked by an immune response.
Background: The pathogenesis of daytime hypercapnia (PaCO 2 ≥ 45 mm Hg) may be directly linked to the existence of obstructive sleep apnea syndrome (OSAS) per se, although only some patients ...
The earliest observations on population patterns of disease and how they might inform medical practice probably occurred during the 17th century, and they continue to the present day, with ...
Expert Rev Clin Immunol. 2009;5(4):381-390. Several intravenous and subcutaneous Ig (SCIg) preparations are available either in a lyophilized form or as ready-to-use solutions. These products ...
With aging there are changes in the cardiovascular system, which result in alterations in cardiovascular physiology. The changes in cardiovascular physiology must be differentiated from the ...
Obe-cel was designed to increase T-cell persistence and reduce T-cell exhaustion and was shown to improve response rates and survival, particularly in patients with low leukemia burden.
Highlights in myasthenia gravis from AANEM 2024 include efficacy data on efgartigimod, ravulizumab, zilucoplan, and first-in-class inebilizumab, as well as safety outcomes in pregnancy for eculizumab.
Increased demands from an aging population and pandemic-related supply shortages leave provinces scrambling to allocate ...
Patients with celiac disease who take an angiotensin receptor blocker (ARB) may experience worse outcomes, such as iron ...
Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...